Correlation Between Morgan Stanley and XTL Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and XTL Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and XTL Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley Direct and XTL Biopharmaceuticals, you can compare the effects of market volatilities on Morgan Stanley and XTL Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of XTL Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and XTL Biopharmaceutica.
Diversification Opportunities for Morgan Stanley and XTL Biopharmaceutica
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Morgan and XTL is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and XTL Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTL Biopharmaceuticals and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with XTL Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTL Biopharmaceuticals has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and XTL Biopharmaceutica go up and down completely randomly.
Pair Corralation between Morgan Stanley and XTL Biopharmaceutica
Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 0.16 times more return on investment than XTL Biopharmaceutica. However, Morgan Stanley Direct is 6.27 times less risky than XTL Biopharmaceutica. It trades about 0.14 of its potential returns per unit of risk. XTL Biopharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest 1,929 in Morgan Stanley Direct on September 26, 2024 and sell it today you would earn a total of 172.00 from holding Morgan Stanley Direct or generate 8.92% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 71.43% |
Values | Daily Returns |
Morgan Stanley Direct vs. XTL Biopharmaceuticals
Performance |
Timeline |
Morgan Stanley Direct |
XTL Biopharmaceuticals |
Morgan Stanley and XTL Biopharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Morgan Stanley and XTL Biopharmaceutica
The main advantage of trading using opposite Morgan Stanley and XTL Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, XTL Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTL Biopharmaceutica will offset losses from the drop in XTL Biopharmaceutica's long position.Morgan Stanley vs. Century Aluminum | Morgan Stanley vs. Global E Online | Morgan Stanley vs. Kaiser Aluminum | Morgan Stanley vs. Harmony Gold Mining |
XTL Biopharmaceutica vs. Nice | XTL Biopharmaceutica vs. The Gold Bond | XTL Biopharmaceutica vs. Bank Leumi Le Israel | XTL Biopharmaceutica vs. ICL Israel Chemicals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
CEOs Directory Screen CEOs from public companies around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |